WHO Grade 3 Glioma
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy (NCT04650204) | Mayo Clinic | 2020-12-04 |
| Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma (NCT03919071) | National Cancer Institute (NCI) | 2020-02-20 |
| Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations (NCT03212274) | National Cancer Institute (NCI) | 2019-01-30 |
| Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma (NCT03180502) | NRG Oncology | 2018-01-23 |
| Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas (NCT02323880) | Children's Oncology Group | 2015-10-30 |
Track WHO Grade 3 Glioma automatically
Every clearance here is in the API, with alerts when new ones post.